Roxanne Toivanen

2.3k total citations
21 papers, 1.5k citations indexed

About

Roxanne Toivanen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cell Biology. According to data from OpenAlex, Roxanne Toivanen has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Roxanne Toivanen's work include Prostate Cancer Treatment and Research (19 papers), Cancer Cells and Metastasis (8 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Roxanne Toivanen is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Cancer Cells and Metastasis (8 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Roxanne Toivanen collaborates with scholars based in Australia, United States and United Kingdom. Roxanne Toivanen's co-authors include Michael M. Shen, Renea A. Taylor, Gail P. Risbridger, Sarah K. Bergren, Mark Frydenberg, Maho Shibata, LaMont Barlow, Chee Wai Chua, Ketan K. Badani and Ming Lei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Cell Biology and Development.

In The Last Decade

Roxanne Toivanen

21 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roxanne Toivanen Australia 15 937 597 558 374 177 21 1.5k
Lisha G. Brown United States 27 1.0k 1.1× 985 1.6× 1.0k 1.8× 383 1.0× 166 0.9× 47 2.0k
Whitney Banach‐Petrosky United States 14 638 0.7× 905 1.5× 367 0.7× 264 0.7× 175 1.0× 16 1.4k
Chee Wai Chua Hong Kong 18 484 0.5× 1.0k 1.7× 741 1.3× 406 1.1× 96 0.5× 29 1.6k
Manuela Sarti Italy 16 434 0.5× 893 1.5× 537 1.0× 289 0.8× 152 0.9× 28 1.7k
Kuniharu Miyajima Japan 17 328 0.4× 969 1.6× 335 0.6× 263 0.7× 71 0.4× 37 1.5k
Bu-Er Wang United States 10 440 0.5× 519 0.9× 324 0.6× 191 0.5× 85 0.5× 14 946
Awad Jarrar United States 14 265 0.3× 651 1.1× 736 1.3× 350 0.9× 79 0.4× 26 1.5k
Neel Shah United States 12 827 0.9× 484 0.8× 232 0.4× 317 0.8× 255 1.4× 20 1.2k
Karsten Gravdal Norway 16 354 0.4× 620 1.0× 465 0.8× 330 0.9× 46 0.3× 28 1.2k
Qingfu Zhang China 22 376 0.4× 816 1.4× 377 0.7× 531 1.4× 74 0.4× 63 1.4k

Countries citing papers authored by Roxanne Toivanen

Since Specialization
Citations

This map shows the geographic impact of Roxanne Toivanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxanne Toivanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxanne Toivanen more than expected).

Fields of papers citing papers by Roxanne Toivanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxanne Toivanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxanne Toivanen. The network helps show where Roxanne Toivanen may publish in the future.

Co-authorship network of co-authors of Roxanne Toivanen

This figure shows the co-authorship network connecting the top 25 collaborators of Roxanne Toivanen. A scholar is included among the top collaborators of Roxanne Toivanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxanne Toivanen. Roxanne Toivanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keerthikumar, Shivakumar, Hong Wang, Belinda Phipson, et al.. (2025). Single‐cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology. Molecular Oncology. 19(10). 2776–2796. 1 indexed citations
2.
Toivanen, Roxanne, Laura H. Porter, Zhuoer Li, et al.. (2021). Hidden clues in prostate cancer – Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification. Cancer Letters. 524. 182–192. 4 indexed citations
3.
Clouston, David, Mark Frydenberg, Dragan Ilić, et al.. (2021). Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta‐analysis. British Journal of Urology. 130(4). 420–433. 10 indexed citations
4.
Risbridger, Gail P., Roxanne Toivanen, & Renea A. Taylor. (2018). Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models. Cold Spring Harbor Perspectives in Medicine. 8(8). a030536–a030536. 61 indexed citations
5.
Zou, Min, Roxanne Toivanen, Antonina Mitrofanova, et al.. (2017). Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer. Cancer Discovery. 7(7). 736–749. 240 indexed citations
6.
Toivanen, Roxanne & Michael M. Shen. (2017). Prostate organogenesis: tissue induction, hormonal regulation and cell type specification. Development. 144(8). 1382–1398. 132 indexed citations
7.
Toivanen, Roxanne, et al.. (2016). Basal Progenitors Contribute to Repair of the Prostate Epithelium Following Induced Luminal Anoikis. Stem Cell Reports. 6(5). 660–667. 53 indexed citations
8.
Wang, Zhu A., Roxanne Toivanen, Sarah K. Bergren, Pierre Chambon, & Michael M. Shen. (2014). Luminal Cells Are Favored as the Cell of Origin for Prostate Cancer. Cell Reports. 8(5). 1339–1346. 106 indexed citations
9.
Chua, Chee Wai, Maho Shibata, Ming Lei, et al.. (2014). Single luminal epithelial progenitors can generate prostate organoids in culture. Nature Cell Biology. 16(10). 951–961. 268 indexed citations
10.
Risbridger, Gail P., Renea A. Taylor, David Clouston, et al.. (2014). Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis. European Urology. 67(3). 496–503. 96 indexed citations
11.
Shen, Michael M., Chee Wai Chua, Maho Shibata, et al.. (2014). Culture of mouse prostate organoids. Protocol Exchange. 2 indexed citations
12.
Lawrence, Mitchell G., Renea A. Taylor, Roxanne Toivanen, et al.. (2013). A preclinical xenograft model of prostate cancer using human tumors. Nature Protocols. 8(5). 836–848. 75 indexed citations
13.
Toivanen, Roxanne, et al.. (2013). 946 Identification of castrate-resistant cancer repopulating cells in localised prostate tumours. European Urology Supplements. 12(1). e946–e946. 1 indexed citations
14.
Toivanen, Roxanne, Mark Frydenberg, Declan Murphy, et al.. (2013). A Preclinical Xenograft Model Identifies Castration-Tolerant Cancer-Repopulating Cells in Localized Prostate Tumors. Science Translational Medicine. 5(187). 187ra71–187ra71. 47 indexed citations
15.
Taylor, Renea A., Roxanne Toivanen, Mark Frydenberg, et al.. (2012). Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status. Stem Cells. 30(8). 1786–1786. 4 indexed citations
16.
Toivanen, Roxanne, Renea A. Taylor, David Pook, Stuart J. Ellem, & Gail P. Risbridger. (2012). Breaking through a roadblock in prostate cancer research: An update on human model systems. The Journal of Steroid Biochemistry and Molecular Biology. 131(3-5). 122–131. 33 indexed citations
17.
Taylor, Renea A., Roxanne Toivanen, Mark Frydenberg, et al.. (2012). Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status. Stem Cells. 30(6). 1087–1096. 68 indexed citations
18.
Toivanen, Roxanne, David M. Berman, Hong Wang, et al.. (2011). Brief Report: A Bioassay to Identify Primary Human Prostate Cancer Repopulating Cells. Stem Cells. 29(8). 1310–1314. 34 indexed citations
19.
Taylor, Renea A., Roxanne Toivanen, & Gail P. Risbridger. (2010). Stem cells in prostate cancer: treating the root of the problem. Endocrine Related Cancer. 17(4). R273–R285. 52 indexed citations
20.
McPherson, Stephen J., Preetika Balanathan, Shelley Hedwards, et al.. (2010). Estrogen receptor–β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediated. Proceedings of the National Academy of Sciences. 107(7). 3123–3128. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisha G. Brown Breakdown of academic impact, for papers by Whitney Banach‐Petrosky Breakdown of academic impact, for papers by Chee Wai Chua Breakdown of academic impact, for papers by Manuela Sarti Breakdown of academic impact, for papers by Kuniharu Miyajima Breakdown of academic impact, for papers by Bu-Er Wang Breakdown of academic impact, for papers by Awad Jarrar Breakdown of academic impact, for papers by Neel Shah Breakdown of academic impact, for papers by Karsten Gravdal Breakdown of academic impact, for papers by Qingfu Zhang
Rankless by CCL
2026